Celladon Announces Results of Special Meeting
21 mars 2016 16h05 HE
|
Celladon Corporation
SAN DIEGO, March 21, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today that, based upon the final vote count certified by the independent inspector of elections for the...
ISS and Glass Lewis Recommend Celladon Corporation Shareholders Vote "FOR" Proposed Merger
09 mars 2016 16h05 HE
|
Celladon Corporation
SAN DIEGO, March 09, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today that Institutional Shareholder Services ("ISS") and Glass Lewis & Co., two of the leading...
Celladon Sets Date for Special Meeting of Stockholders
10 févr. 2016 16h57 HE
|
Celladon Corporation
SAN DIEGO, Feb. 10, 2016 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN) announced today it has set a date for a special meeting of its stockholders to vote on matters related to the proposed...
Eiger BioPharmaceuticals and Celladon Corporation Sign Merger Agreement
18 nov. 2015 22h36 HE
|
Celladon Corporation
--Celladon-Eiger Proposed Merger Creates a Biopharmaceutical Company With Diverse Portfolio of Four Novel Drug Development Programs Addressing Orphan Diseases-- --Concurrent Financing of $39.5...
Celladon Reports Second Quarter 2015 Financial Results
11 août 2015 16h15 HE
|
Celladon Corporation
SAN DIEGO, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), today announced financial results for the quarter ended June 30, 2015 and recent corporate updates.
Second Quarter...
Celladon Corporation Provides Business Update
26 juin 2015 06h00 HE
|
Celladon Corporation
Process of Seeking Merger or Sale Underway
Company Not Pursuing Further Development of Existing Programs
SAN DIEGO, June 26, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN),...
Celladon Corporation Announces Strategic Direction Following Review of CUPID2 Data
01 juin 2015 07h00 HE
|
Celladon Corporation
-- Company to Seek Acquisition or Partnership --
-- Wedbush PacGrow Healthcare Securities Retained as Exclusive Financial Advisor --
-- Paul Cleveland Named Chief Executive Officer --
SAN...
Celladon Reports First Quarter 2015 Financial Results
14 mai 2015 16h30 HE
|
Celladon Corporation
SAN DIEGO, May 14, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company with industry-leading expertise in the development of cardiovascular gene...
Celladon Reports Negative Results for CUPID2 Trial of MYDICAR(R) in Advanced Heart Failure
26 avr. 2015 16h40 HE
|
Celladon Corporation
- Investigational gene therapy fails to meet primary and secondary endpoints -
- Investor conference call and webcast Monday at 8:30 a.m. ET (5:30 a.m. PT) -
SAN DIEGO, April 26, 2015 (GLOBE...
Celladon Reports Fourth Quarter and Year-End 2014 Financial Results and Recent Highlights
30 mars 2015 16h05 HE
|
Celladon Corporation
CUPID2 Topline Data Release on Track for Late April
Conference Call March 31, 2015 at 8:30 a.m. Eastern Time
SAN DIEGO, March 30, 2015 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a...